IL16 and colorectal cancer: First, we observed the distribution of T-cell growth factor IL-2 and T-cell activator IL-16 in the peripheral blood and found that IL-2 concentrations were increased in the peripheral blood of patients with stage IV colorectal cancer (one-way ANOVA, IL-2 control vs stage IV, p = 0.0226) (Figure 5A).